SECTOR ANALYSIS

Bispecific Antibody Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Bispecific Antibody Oncology stocks tracked by BiotechSigns

← Full ScreenerFDA CalendarAll Sectors
Companies
18
Avg Score
55
Top Grade
B
Bispecific Antibody Oncology Companies18 tracked
TickerCompanyScoreGradeSectorSignals
NUVBNuvation Bio69BOncology
LBPHLongboard Pharmaceuticals66BOncology
SNDXSyndax Pharmaceuticals63COncology
ZYMZymeworks Inc61CBispecific Antibody
KURAKura Oncology, Inc.60COncology
INCYIncyte Corporation60COncology
HOOKHOOKIPA Pharma59COncology
CELCCelcuity Inc58COncology
HCMHUTCHMED China58COncology
NUVLNuvalent Inc57COncology
EXELExelixis Inc55COncology
KRONKronos Bio53COncology
BOLDBold Therapeutics52COncology
CRVSCorvus Pharmaceuticals49DOncology
TOIThe Oncology Institute, Inc.48DOncology
BGNEBeiGene Ltd44DOncology
RAPTRAPT Therapeutics44DOncology
IMGNImmunoGen Inc42DOncology
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSigns grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.